Flora Fertility has raised $5 million in seed funding to build individually owned fertility insurance that isn’t tied to an employer. The round was led by ManchesterStory with participation from Slauson & Co., BDC, and existing investors. Flora previously raised a $1.5M pre-seed round in 2024.
Coverage starts at $15 per month and spans diagnostics, medications, IUI, and IVF. Policies use AI-driven risk underwriting and are portable – designed to follow women across jobs, career breaks, and freelance stints. The company is targeting women aged 20-34 and positioning itself as a more affordable route to proactive family planning than elective egg freezing.
The market gap is straightforward: fertility treatment can cost tens of thousands of dollars, the vast majority of people who need it can’t afford it, and most existing coverage is employer-dependent. That means coverage disappears the moment someone changes jobs, goes independent, or works for a company that doesn’t offer fertility benefits – which is most companies.
Co-founded by Laura J. McDonald and Dr. Christy Lane, Flora is partnering with women’s health apps and SMBs to reach what it estimates is a market of roughly 10 million prospective users.
If the model works, Flora could expand who gets access to fertility care by making it something women can plan and pay for on their own terms rather than hoping their employer offers it as a perk.
